PHC Holdings Corporation
Stock Price Chart
2026/01/16 UpdatedPrice Trend
2026/01/16 UpdatedPrice & Trading Details
2026/01/16 UpdatedPRICE
TRADING
Analyst Recommendations 7 analysts
Updated 2026/01/11Shareholder Composition
Updated 2026/01/11Major Holders
Updated 2026/01/11| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
406.3K | -6.47% | |
|
WisdomTree Trust-WisdomTree Japan Hedged Equity Fund
|
241.0K | +15.37% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
208.7K | -28.70% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
131.7K | 0.00% | |
|
iShares Trust-iShares MSCI EAFE Small-Cap ETF
|
101.8K | 0.00% | |
|
VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Small-Cap
|
99.9K | +15.09% |
Dividend History 1Years Growth
Updated 2026/01/11| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥42 | +7.7% |
| 2024 | ¥39 | -45.8% |
| 2023 | ¥72 | -2.7% |
| 2022 | ¥74 | - |
Financial Performance
2026/01/11 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥340,452M | ¥356,434M | ¥353,900M | ¥361,593M |
| Gross Profit | ¥165,237M | ¥169,132M | ¥157,975M | ¥166,224M |
| Operating Income | ¥8,529M | ¥20,515M | ¥1,738M | ¥22,952M |
| Pretax Income | ¥10,522M | ¥20,410M | ¥2,215M | ¥24,085M |
| Net Income | -¥8,460M | -¥3,221M | -¥12,892M | ¥10,484M |
| EPS | -¥70.78 | -¥25.84 | -¥102.48 | ¥82.58 |
| Operating Margin | 2.51% | 5.76% | 0.49% | 6.35% |
| Balance Sheet | ||||
| Total Assets | ¥591,320M | ¥561,567M | ¥564,327M | ¥532,482M |
| Total Equity | ¥135,374M | ¥138,008M | ¥139,515M | ¥141,639M |
| Total Liabilities | ¥455,946M | ¥423,559M | ¥424,812M | ¥390,843M |
| Cash | ¥95,232M | ¥60,933M | ¥47,044M | ¥39,592M |
| Interest-bearing Debt | ¥307,936M | ¥292,615M | ¥285,045M | ¥255,260M |
| Equity Ratio | 22.89% | 24.58% | 24.72% | 26.60% |
| D/E Ratio | 2.27 | 2.12 | 2.04 | 1.80 |
| Cash Flow | ||||
| Operating CF | ¥51,053M | ¥21,376M | ¥41,304M | ¥41,941M |
| Investing CF | -¥12,521M | -¥17,520M | -¥21,072M | -¥8,473M |
| Financing CF | -¥7,015M | -¥40,832M | -¥39,139M | -¥39,068M |
| Free CF | ¥39,317M | ¥9,860M | ¥26,674M | ¥30,331M |
| Efficiency | ||||
| ROE | -6.25% | -2.33% | -9.24% | 7.40% |
| ROA | -1.43% | -0.57% | -2.28% | 1.97% |
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥1,244
Rating Score: - (Based on 7 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
PHC Holdings Corporation, together with its subsidiaries, provides healthcare digital and precision technology solutions in Japan, Europe, North America, and internationally. The company operates in three segments: Diabetes Management; Healthcare Solutions; and Diagnostic and Life Sciences. It offers precision anatomical pathology for cancer, including tissue processors, digital pathology, and histology consumables; cell growth and preservation, such as CFC-free ultra-low temperature freezers, CO2 incubators, and live cell metabolic analyzer and cell expansion bioreactor system; and diagnostic testing comprising clinical testing, diagnostic reagents, and digital diabetes management solutions. The company also provides patient record and billing solutions, which include electronic medical record systems and receipt systems, systems for pharmacies, and wellness and prevention; diabetes management technology, such as blood and continuous glucose monitoring systems; and medical device and drug delivery comprising contract development and manufacturing services, drug delivery systems, and digital health. It serves patients, healthcare professionals, and researchers. The company was formerly known as Panasonic Healthcare Holdings Co., Ltd. and changed its name to PHC Holdings Corporation in April 2018. PHC Holdings Corporation was founded in 1948 and is headquartered in Chiyoda, Japan.
